Novel cardiovascular drugs in clinical trials

Area of Science:

• Cardiovascular Medicine
• Pathophysiology
• Molecular Biology

Background:

• Cardiovascular diseases (CVDs) are a primary cause of global morbidity and mortality.
• Increasing life expectancy correlates with a rise in age-related cardiovascular conditions.
• Atherosclerosis contributes significantly to CVDs, making them the leading cause of death in developed nations.

Purpose of the Study:

• To explore the role of endothelial dysfunction in cardiovascular disease pathophysiology.
• To identify novel cellular therapeutic targets for CVDs.
• To review potential preventative and therapeutic strategies for atherosclerosis.

Main Methods:

• Review of recent advances in cardiovascular disease pathophysiology.
• Analysis of molecular signaling pathways implicated in endothelial dysfunction.
• Examination of studies on various therapeutic agents and cellular targets.

Main Results:

• Endothelial dysfunction is a key factor in cardiovascular disease development.
• Potential cellular targets include vascular smooth muscle cells, monocytes/macrophages, platelets, and endothelial cells.
• Therapeutic approaches such as antiplatelet agents, antioxidants, and ACE inhibitors show promise.

Conclusions:

• Understanding molecular pathways offers new therapeutic avenues for CVDs.
• Targeting specific cellular mechanisms may prevent or slow disease progression.
• Continued research is crucial for developing effective treatments for atherosclerosis-related events like heart attacks and strokes.